Viewing Study NCT01286818


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-01-26 @ 9:03 PM
Study NCT ID: NCT01286818
Status: COMPLETED
Last Update Posted: 2014-10-06
First Post: 2011-01-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colon Cancer View
None Rectal Cancer View